Pre-market hot trades in US stocks: Oriental Culture down 11.08% pre-market; Franco-Neveda down 7.67% pre-market

Pre-market Hot Trades in US Stocks Oriental Culture is down 11.08% in pre-market trading. There has been no significant news recently; trading is active with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news Franco-Nevada is down 7.67% in pre-market trading. Based on recent key news: On March 18, Franco-Nevada announced an upcoming Investor Day event, and market expectations for the company's future strategy may lead to stock price fluctuations. Source: Franco-Nevada official announcement On March 16, I-80 Gold completed a $250 million royalty financing deal with Franco-Nevada, which may affect Franco-Nevada's financial condition. Source: Reuters On March 17, Scotiabank raised Franco-Nevada's target price from $283 to $286, reflecting market optimism about its future performance. Source: Scotiabank analysis report. Gold prices remain strong, and market volatility risks are high. Top Gainers in Pre-market US Stocks China Natural Resources is up 56.06% in pre-market trading. Based on recent key news: On March 19, China Natural Resources announced the signing of a non-binding letter of intent with Feishang Group to acquire a majority stake in HooRii Technology. This acquisition marks the company's strategic shift towards the physical AI sector, with an expected transaction amount of $37 million to $40 million, to be paid in cash and stock. This news has significantly boosted the stock price. Source: Company announcement On March 19, trading volume for China Natural Resources surged, exceeding 16.6 million shares, compared to an average daily trading volume of about 42,000 shares over the past three months, indicating strong investor interest in the company's strategic transformation. Source: Company announcement On March 19, China Natural Resources plans to strengthen its mining operations while transitioning to the AI sector, forming a dual business focus. This move is seen as a potential driver for the company's business growth. Source: Company announcement. Industry transformation has attracted market attention, leading to a surge in trading volume. Serina Therapeutics is up 53.90% in pre-market trading. Based on recent key news: On March 19, Serina Therapeutics announced a $30 million private placement agreement. This news has significantly boosted the stock price, as market expectations for the company's improved financial condition have increased. Source: GlobeNewswire On March 18, the company plans to raise $15 million through the issuance of common stock and pre-funded warrants, with the first tranche of funding expected to be completed by March 20. This move provides the company with funding to support its Parkinson's disease drug SER-252 trial Source: MT Newswires On March 19, management emphasized the progress of the SER-252 trial and positive feedback from the FDA, which enhanced market confidence in the company's future development. Source: Nasdaq The biotechnology industry has been quite volatile recently, and investment should be approached with caution. Mobix Labs pre-market rose 34.78%. Based on recent news, On March 19, Mobix Labs announced that it was selected by a major arms manufacturer to participate in an early feasibility program regarding smart ammunition technology, aimed at anti-drone applications. The program focuses on assessing technology to improve the responsiveness of ammunition when approaching fast-moving aerial targets (such as drones). Although the program is limited to feasibility assessment and does not include production or deployment, this news significantly boosted market confidence, driving the stock price up sharply. Recent attention on the military industry has increased, and technological innovation is highly anticipated